Cargando…

Ribozymes targeting the tumor suppressor BRCA1 lead to increased chemosensitivity to cisplatin and etoposide and chemoresistance to microtubule-interfering agents in HBL100 breast cancer cell line

Detalles Bibliográficos
Autores principales:	Lafarge, S, Ferrara, M, Bignon, YJ
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2000
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300822/ http://dx.doi.org/10.1186/bcr123

Ejemplares similares

Characterization of etoposide- and cisplatin-chemoresistant retinoblastoma cell lines
por: Busch, Maike, et al.
Publicado: (2018)

Presence and function of Hbl B’, the fourth protein component encoded by the hbl operon in Bacillus cereus
por: Jessberger, Nadja, et al.
Publicado: (2022)

Resveratrol Inhibits Proliferation in HBL-52 Meningioma Cells
por: Hu, Shun-an, et al.
Publicado: (2019)

The Crystal Structure of Bacillus cereus HblL(1)
por: Worthy, Harley L., et al.
Publicado: (2021)

An Exceptionally Favorable Response to Etoposide and Cisplatin
por: Valecha, Gautam, et al.
Publicado: (2015)

Facile synthesis of biocompatible gold nanoparticles from Vites vinefera and its cellular internalization against HBL-100 cells
por: Amarnath, Kanchana, et al.
Publicado: (2011)

Chemosensitization of U-87 MG Glioblastoma Cells by Neobavaisoflavone towards Doxorubicin and Etoposide
por: Maszczyk, Mateusz, et al.
Publicado: (2022)

Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report
por: Das, Sunil Kumar, et al.
Publicado: (2022)

Egr-1 regulates the transcription of the BRCA1 gene by etoposide
por: Shin, Soon Young, et al.
Publicado: (2013)

MicroRNA-217 acts as a tumor suppressor and correlates with the chemoresistance of cervical carcinoma to cisplatin
por: Yin, Zhaojun, et al.
Publicado: (2019)

ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel
por: Wang, Lifeng, et al.
Publicado: (2008)

BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases
por: Uhrhammer, Nancy, et al.
Publicado: (2008)

Effects of trans-(±)-kusunokinin on chemosensitive and chemoresistant ovarian cancer cells
por: Mad-Adam, Nadeeya, et al.
Publicado: (2022)

Bacillus cereus cytotoxins Hbl, Nhe and CytK are secreted via the Sec translocation pathway
por: Fagerlund, Annette, et al.
Publicado: (2010)

Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin
por: Mitry, E, et al.
Publicado: (1999)

MicroRNA-217 Acts as a Tumor Suppressor and Correlates with the Chemoresistance of Cervical Carcinoma to Cisplatin [Retraction]
Publicado: (2023)

Evaluation of the efficacy of cisplatin–etoposide and the role of thoracic radiotherapy and prophylactic cranial irradiation in LCNEC
por: Prelaj, Arsela, et al.
Publicado: (2017)

Cell fate determination in cisplatin resistance and chemosensitization
por: Luong, Khanh V., et al.
Publicado: (2016)

The Bacillus cereus Hbl and Nhe Tripartite Enterotoxin Components Assemble Sequentially on the Surface of Target Cells and Are Not Interchangeable
por: Sastalla, Inka, et al.
Publicado: (2013)

Natural Human Interferon‐γ Derived from Lipopolysaccharide‐stimulated Human Myelomonocytic HBL‐38 Cells
por: Ando, Shunsaku, et al.
Publicado: (1988)

In vitro expression of cytokeratin 18, 19 and tube formation of adipose‐derived stem cells induced by the breast epithelial cell line HBL‐100
por: Yang, Jie, et al.
Publicado: (2015)

Outcome of treatment with EMA/EP (etoposide methotrexate and actinomycin-D/ etoposide and cisplatin) regimen in gestational trophoblastic neoplasia
por: Aminimoghaddam, Soheila, et al.
Publicado: (2018)

Effect of small interfering RNA 3'-end overhangs on chemosensitivity to thymidylate synthase inhibitors
por: Schmitz, John C, et al.
Publicado: (2011)

TRIM44 promotes BRCA1 functions in HR repair to induce Cisplatin Chemoresistance in Lung Adenocarcinoma by Deubiquitinating FLNA
por: Zhang, Shuai, et al.
Publicado: (2022)

Evaluation of Possible Neobavaisoflavone Chemosensitizing Properties towards Doxorubicin and Etoposide in SW1783 Anaplastic Astrocytoma Cells
por: Maszczyk, Mateusz, et al.
Publicado: (2023)

MicroRNA-217 Acts as a Tumor Suppressor and Correlates with the Chemoresistance of Cervical Carcinoma to Cisplatin [Expression of Concern]
Publicado: (2022)

Impact of Etoposide on BRCA1 Expression in Various Breast Cancer Cell Lines
por: Zhang, Xi, et al.
Publicado: (2017)

S100A9 regulates cisplatin chemosensitivity of squamous cervical cancer cells and related mechanism
por: Zhao, Chuchu, et al.
Publicado: (2018)

Cisplatin for cancer therapy and overcoming chemoresistance
por: Ranasinghe, Ranmali, et al.
Publicado: (2022)

Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide-carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer: a retrospective analysis of 62 cases
por: Li, Yue-Ya, et al.
Publicado: (2015)

A Phase III Randomized Study Comparing a Chemotherapy with Cisplatin and Etoposide to a Etoposide Regimen without Cisplatin for Patients with Extensive Small-Cell Lung Cancer
por: Berghmans, Thierry, et al.
Publicado: (2017)

Chemosensitizing and nephroprotective effect of resveratrol in cisplatin –treated animals
por: Osman, Abdel-Moneim M, et al.
Publicado: (2015)

Autophagy modulating agents as chemosensitizers for cisplatin therapy in cancer
por: Gąsiorkiewicz, Bartosz Mateusz, et al.
Publicado: (2020)

Comparison of Ifosfamide, Carboplatin and Etoposide versus Etoposide, Steroid, and Cytarabine Cisplatin as Salvage Chemotherapy in Patients with Refractory or Relapsed Hodgkin's lymphoma
por: Mehrzad, Valiollah, et al.
Publicado: (2017)

First line combination chemotherapy with cisplatin and etoposide in advanced ovarian cancer.
por: Athanassiou, A. E., et al.
Publicado: (1989)

Feasibility of combination chemotherapy with cisplatin and etoposide for haemodialysis patients with lung cancer
por: Watanabe, R, et al.
Publicado: (2003)

Schedule-dependent response of neuroblastoma cell lines to combinations of etoposide and cisplatin
por: Meczes, E L, et al.
Publicado: (2002)

Uncommon response of cisplatin and etoposide for treatment of advanced medullary thyroid carcinoma
por: Panomuppakarn, Nathamon, et al.
Publicado: (2017)

BRCA1 Expression is an Important Biomarker for Chemosensitivity: Suppression of BRCA1 Increases the Apoptosis via Up-regulation of p53 and p21 During Cisplatin Treatment in Ovarian Cancer Cells
por: Horiuchi, Akiko, et al.
Publicado: (2007)

BRCA1 and BRCA2 Tumor Suppressor Function in Meiosis
por: Li, Qianyan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_68ttaupdl5f2566e0s1uls36uh